Driving meniscus health forward

See you at the #isoK24 in May!

MEFISTO will be represented at the annual Isokinetic Conference #isoK24, the landmark event of football medicine that will take place at the Madrid Civitas Metropolitano Stadium on 25-25 May 2024.

MEFISTO publication in Heliyon

Congratulations to the MEFISTO partners CNR, Geistlich and UHREG on a great team work that resulted in a publication in Heliyon on Development of a highly concentrated collagen ink for the creation of a 3D printed meniscus.

Read it here.

Further publications are in the pipeline... stay tuned

MEFISTO in "Horizon - The European research and innovation magazine"

MEFISTO is featured in "Horizon - The European research and innovation magazine" with the article "The quest to bring osteoarthritis to its knees".

Millions of people in Europe and elsewhere suffer degeneration of joint cartilage in the knee, driving EU research into better treatments. MEFISTO is part of this endeavour! 

Enjoy reading!

MEFISTO joint publication

We are pleased to announce an important MEFISTO publication: Our article "Biofunctionalization of 3D printed collagen with bevacizumab-loaded microparticles targeting pathological angiogenesis" has just been published in the Journal of Controlled Release.

Highlights of this publication include the following: 

- Release of bevacizumab from PLGA microparticles can be controlled.
- Degradation of bevacizumab during in vitro release was observed.
- Bevacizumab-loaded microparticles reduce angiogenesis in a 3D cellular model.
- Complex biomimicking structures by 3D printing microparticles-loaded collagen.

This work involved 4 MEFISTO partners: The University of Santiago de Compostela, the UMC Utrecht, the Consiglio Nationale delle Ricerche Napoli and Geistlich Pharma joined forces for this great result.

Enjoy reading!

ONtheGo Podcast with Elizaveta Kon

Want to learn more about orthoregeneration? In this podcast episode from ON, the orthoregeneration network, Elizaveta Kon (partner HUNIMED) and Jari Dahmen (Amsterdam UMC) talk about the MEFISTO Project and treating damage to the meniscus in the future.


The MEFISTO Session at ICRS today was a productive exchange with 3 presentations focusing on:

  • an update of the MEFISTO project with the 2 approaches (resorbable & non-resorbable) and functionalization of the devices (Elizaveta Kon, Humanitas University, Milan)
  • presentation of the technology developments of functionalized materials for meniscus regeneration by MEFISTO (Mylène De Ruijter, University Medical Center Utrecht)
  • and the morphological profiling of patients to predict post-meniscectomy OA (Peter Verdonk, University of Antwerp)

The presentations were followed by a very interesting round table discussion.

MEFISTO Workshop @ ICRS Focus Meeting on April 27

Come learn more about prevention and prediction of Post-Meniscectomy OA at of the MEFISTO workshop that will be held on Thursday, 27 April at the ICRS Nice Focus meeting. This event will give you the opportunity to discuss with three of MEFISTO's researchers Elizaveta Kon from HUNIMED, Mylene De Ruiiter from UMCU and Peter Verdonk from UAntwerpen.

Register online.

MEFISTO in Santiago de Compostela

We are just back from our 8th consortium meeting in Santiago de Compostela, Spain. As always it was nice to meet and discuss the project progress. This time the focus laid on planning of the final year during which we strive to validate novel solutions to treat meniscus loss in vitro and in vivo. 

In an extended lab tour of the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS) we had the chance to visit the impressing infrastructure of the center, from massive high-throughput screening via animal testing to nuclear medicine. 

We also learned a lot about the nature, culture and cuisine of our host country Galicia and Santiago de Compostela. Thanks again for everything to Maria José Alonso and your team!

Amazing Tel Aviv

Many thanks to Active Implants for a very fruitful meeting that allowed us to combine necessary discussions on how to shape further project time with insights into their interesting company history and latest achievements.

Insights into the innovation mecca of Tel-Aviv rounded off our visit, not to mention the rich sights and culinary delights of the region that we were able to enjoy. Thank you so much, Active Implants!

MEFISTO presented at THE MENISCUS conference in Luxembourg

The MEFISTO project was presented at The Meniscus Congress in Luxembourg taking place from 7-9 July 2022: www.the-meniscus.org

On Thursday Jonas Grammens presented on 'Can identification of bone morphology help us predict the future of the knee?'

In the afternoon Elizaveta Kon announced the educational meniscus discovery series: 'All you need to know about meniscus'.

On Friday, she also introduced the MEFISTO project to the audience and provided an excellent overview and current status of the project in her talk 'New frontiers on meniscal regeneration: The MEFISTO European Project'

Another great opportunity to inform stakeholders about the project and increase the visibility of MEFISTO!

Impressions from the MEFISTO session at ESSKA in Paris

To learn more about the MEFISTO Meniscus Discovery series, new technologies for Meniscal regeneration and predictive performance, follow us on @MEFISTO_H2020 and our website

Join MEFISTO at the ESSKA congress!

MEFISTO strongly represented at the 20th ESSKA Congress, 27-29 April 2022 in Paris! In a dedicated session from 13h45 to 14.35 on 29 April 5 MEFISTO researchers will present:

- 13.45 CEST: All you need to know about meniscus: Meniscus Discovery series - Elizaveta Kon, Italy

- 13.55 CEST: Meniscal preservation possible? ortobiologics - Berardo Di Matteo, Italy

- 14.05 CEST: Meniscal repair- the future - Pablo Gelber, Spain

- 14.15 CEST: New technologies for Meniscal regeneration: Mefisto approach - Jos Malda, the Netherlands

- 14.25 CEST: Do we know the future? - Jonas Grammens, Belgium

Stay tuned: More MEFISTO at the ICRS congress

At the ICRS congress in Berlin also MEFISTO researchers from Regensburg, Antwerpen and Utrecht presented today: While Girish Pattappa from the university hospital Regensburg presented "Meniscus: Future developments from a cellular and molecular perspective", Riccardo Levato (photo) from Utrecht university hospital focussed on "New Technologies for Meniscal Regeneration: The Mefisto Approach" and Jonas Grammens from Antwerp university hospital imagines "How to predict the future -Morphological Profiling".

MEFISTO and the Meniscus Discovery Series presented at ICRS World congress

The MEFISTO project – and especially the Meniscus Discovery Series – were presented in a special session at the 16th ICRS World congress by MEFISTO scientific Coordinator Elizaveta Kon today. We are also proud to announce that Prof. Kon has been nominated as incoming ICRS President.

The  'Meniscus Discovery Series – episode 1 ' is the first in a series of documentaries on the meniscus. It contains interviews, animations, patient stories etc. The series is aimed to address young orthopedic surgeons & residents. It has been created with the support of the MEFISTO project. 

Watch the trailer:

See the full episode:

MEFISTO publication nominated for the “Nanomaterials 2022 Best Paper Award"

We are pleased to announce that a MEFISTO publication, "Therapeutic Manipulation of Macrophages Using Nanotechnological Approaches for the Treatment of Osteoarthritis" by Aldo Ummarino, Francesco Manlio Gambaro, Elizaveta Kon and Fernando Torres Andón from Universidade de Santiago de Compostela and Humanitas university Milan has been nominated for the “Nanomaterials 2022 Best Paper Award"! 

Please widely share this information to further promote the publication!

What a pleasure to meet in person again!

After a break of 2 years due to the pandemic, we were finally able to meet again in person on 16-17 March 2022. We all appreciated the direct professional discussions, updates, and plans for the next months. Of course we also enjoyed good food and drink, personal conversations and the sights of bella Napoli!

MEFISTO presented at the SIAGASCOT 2022

Our external project advisor Vincenzo Condello presented MEFISTO in his talk on 'Meniscal scaffold: new perspectives vs traditional techniques' at the 1st SIAGASCOT Annual Meeting

New paper in Frontiers in Bioengineering and Biotechnology

Discover this new publication from the UHREG team on isolation of meniscus progenitor using differential fibronectin adhesion and physioxia in the January edition of @FrontBioeng.

MEFISTO well represented at EORS 2021

Four MEFISTO researchers, Elizaveta Kon (HUNIMED), Girish Pattappa (UHREG), Jonas Grammens (UAntwerpen) and Riccardo Levato (UMCU) are presenting at the 29th Annual Meeting of the European Orthopaedic Research Society.

MEFISTO 4th Consortium meeting

The MEFISTO project held its 4th consortium meeting on 2 and 3 December 2020. Due to the COVID 19 pandemic, the meeting was conducted on-line with over 30 participants from all 13 project partners.

Despite limited access to laboratory facilities for the most part of 2020, significant progress has been made on key project deliverables: standard operating procedures for in vitro tests are now established, the 3D database of high-precision knee models after meniscus removal surgery is nearing completion, several resorbable and non-resorbable meniscus device concepts are currently being evaluated and components for the biofunctionalisation of the devices are under development.

To date, 7 publications have been published in scientific journals. They are all openly accessible and the full list of links is available on the MEFISTO website at https://www.mefisto-project.eu/outcomes/.

First prize of the Virgilio project won by a MEFISTO video

Congratulation to Francesco Gambaro for winning the first prize of the Virgilio "Communicating Science" project of Humanitas University with this video aiming at presenting the MEFISTO project to a general public audience.

Live interview of Peter Angele on meniscus regeneration

Join Dr. Peter Angele online for a Live interview organized by the ON Foundation together with Dr. Philip Roessler. The interview will take place on Tuesday, 28th April 2020 from 18:00 CET and it will be live streamed on Facebook Live.

You can find updates and more information on the ON Foundation`s Facebook page



The MEFISTO video is now available on our homepage and on video streaming platforms (Vimeo and YouTube).

In this video experts from the MEFISTO project explain the problem of osteoarthritis occurring after meniscus resection and the approaches we take to solve this problem in the future.


MEFISTO presents at ONstage event

Two members of the MEFISTO team will present at the ONstage event. The event focusses on orthopedic tissue regeneration. It will take place in Dübendorf near Zurich, Switzerland on 18 October 2019.

MEFISTO 2nd Consortium meeting

Post-Brexit scenarios

If the Withdrawal Agreement is ratified before Brexit, UK participation in Horizon 2020 will be ensured until the end of the programme and for the lifetime of projects.
In the event of a no-deal scenario, different rules will apply depending on whether UK bids to EU calls have been submitted before 31 October 2019 or after.
If UK bids to EU calls have been submitted before 31 October 2019, in case of a no-deal brexit the UK government has committed to guarantee competitive UK bids to EU funding submitted before exit, even if they are notified of their success after exit, for the lifetime of the projects.
If UK bids to EU calls have been submitted after 31 October 2019, the funding for successful UK bids will be guaranteed not by the EU but by UKRI itself, which has been appointed to administer the UK’s guarantee and post-EU exit extension. The funding then will be ensured for the lifetime of such projects, even if they last beyond 2020. The UK government is seeking discussions with the European Commission to agree the details of the UK’s continued participation as a third country.
Source: Swisscore, UKRI

MEFISTO Website online

MEFISTO project has officially started

Show more posts

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 814444 (MEFISTO).